Literature DB >> 10739847

Incidence of congenital malformations in children born after ICSI.

U B Wennerholm1, C Bergh, L Hamberger, K Lundin, L Nilsson, M Wikland, B Källén.   

Abstract

The aim of this study was to determine the incidence of congenital malformations in a complete cohort of children born after intracytoplasmic sperm injection (ICSI). The medical records were retrieved for 1139 infants, 736 singletons, 200 sets of twins and one set of triplets. The total number of infants with an identified anomaly was 87 (7.6%), 40 of which were minor. The incidence of malformations in children born after ICSI was also compared with all births in Sweden using data from the Swedish Medical Birth Registry and the Registry of Congenital Malformations. For ICSI children, the odds ratio (OR) for having any major or minor malformation was 1.75 [95% confidence interval (CI) 1.19-2.58] after stratification for delivery hospital, year of birth and maternal age. If stratification for singletons/twins was also done, the OR was reduced to 1.19 (95% CI 0.79-1.81). The increased rate of congenital malformations is thus mainly a result of a high rate of multiple births. The only specific malformation which was found to occur in excess in children born after ICSI was hypospadias (relative risk 3.0, exact 95% CI 1. 09-6.50) which may be related to paternal subfertility.

Entities:  

Mesh:

Year:  2000        PMID: 10739847     DOI: 10.1093/humrep/15.4.944

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  39 in total

Review 1.  Male infertility, pleiotropic genes, and increased risk of diseases in future generations.

Authors:  B Dallapiccola; G Novelli
Journal:  J Endocrinol Invest       Date:  2000-10       Impact factor: 4.256

Review 2.  Genetically determined male infertility and assisted reproduction techniques.

Authors:  T Hargreave
Journal:  J Endocrinol Invest       Date:  2000-11       Impact factor: 4.256

3.  Intracytoplasmic sperm injection: promises and challenges.

Authors:  Shi Wu Wen; Mark Walker; Marie-Claude Léveillé; Art Leader
Journal:  CMAJ       Date:  2004-10-12       Impact factor: 8.262

Review 4.  Nutritional modifications in male infertility: a systematic review covering 2 decades.

Authors:  Ladan Giahi; Shayan Mohammadmoradi; Aida Javidan; Mohammad Reza Sadeghi
Journal:  Nutr Rev       Date:  2015-12-24       Impact factor: 7.110

5.  Conventional in vitro fertilization maybe yields more available embryos than intracytoplasmic sperm injection for patients with no indications for ICSI.

Authors:  Li Ming; Chen Yuan; Zhao Ping; Liu Ping; Qiao Jie
Journal:  Int J Clin Exp Med       Date:  2015-11-15

6.  A prospective randomized trial of conventional in vitro fertilization versus intracytoplasmic sperm injection in unexplained infertility.

Authors:  Shu C Foong; Judy A Fleetham; Joseph A O'Keane; Selma G Scott; Suzanne C Tough; Calvin A Greene
Journal:  J Assist Reprod Genet       Date:  2006-04-19       Impact factor: 3.412

Review 7.  Intracytoplasmic sperm injection (ICSI)--what are the risks?

Authors:  Joseph P Alukal; Dolores J Lamb
Journal:  Urol Clin North Am       Date:  2008-05       Impact factor: 2.241

8.  A meta-analysis of the impact of IVF and ICSI on major malformations after adjusting for the effect of subfertility.

Authors:  Alfred A Rimm; Alyce C Katayama; K Paul Katayama
Journal:  J Assist Reprod Genet       Date:  2011-05-31       Impact factor: 3.412

9.  The risk for four specific congenital heart defects associated with assisted reproductive techniques: a population-based evaluation.

Authors:  Karim Tararbit; Nathalie Lelong; Anne-Claire Thieulin; Lucile Houyel; Damien Bonnet; François Goffinet; Babak Khoshnood
Journal:  Hum Reprod       Date:  2012-11-22       Impact factor: 6.918

10.  Comparison of embryo quality between intracytoplasmic sperm injection and in vitro fertilization in sibling oocytes.

Authors:  R Yoeli; R Orvieto; J Ashkenazi; M Shelef; Z Ben-Rafael; I Bar-Hava
Journal:  J Assist Reprod Genet       Date:  2008-01-19       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.